WHO ICTRP trial
To evaluate efficacy of combination therapy of norepinephrine and milrinone…
CTRI/2024/09/073420 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/09/073420 |
|---|---|
| Public title | To evaluate efficacy of combination therapy of norepinephrine and milrinone against epinephrine alone as a first-line agent in fluid refractory Pediatric septic shock for early resolution of shock in children aged 1 month to 18 years– a randomized controlled trial |
| Scientific title | A combination therapy of norepinephrine and milrinone as a first-line agent in fluid refractory Pediatric septic shock – a randomized controlled trial - Nil |
| Primary sponsor | AIIMS RISHIKESH |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: R652- Severe sepsis |
| Interventions | Intervention1: Combination therapy of Norepinephrine and Milrinone infusion: Combination therapy of Norepinephrine and Milrinone will be used as a first line inotropic agent in fluid refractory Pediatric Septic shock in one arm… |
| Registration date | May 9, 2024 |
| Target size | 164 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: